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Abstract. Animal models of stroke are used extensively to study the mechanisms involved in
the acute and chronic phases of recovery following stroke. A translatable animal model that
closely mimics the mechanisms of a human stroke is essential in understanding recovery proc-
esses as well as developing therapies that improve functional outcomes. We describe a photo-
thrombosis stroke model that is capable of targeting a single distal pial branch of the middle
cerebral artery with minimal damage to the surrounding parenchyma in awake head-fixed mice.
Mice are implanted with chronic cranial windows above one hemisphere of the brain that allow
optical access to study recovery mechanisms for over a month following occlusion. Additionally,
we study the effect of laser spot size used for occlusion and demonstrate that a spot size with
small axial and lateral resolution has the advantage of minimizing unwanted photodamage while
still monitoring macroscopic changes to cerebral blood flow during photothrombosis. We show
that temporally guiding illumination using real-time feedback of blood flow dynamics also mini-
mized unwanted photodamage to the vascular network. Finally, through quantifiable behavior
deficits and chronic imaging we show that this model can be used to study recovery mechanisms
or the effects of therapeutics longitudinally. © The Authors. Published by SPIE under a Creative
Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in part
requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.NPh.7.1.015005]
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1 Introduction
Stroke is the leading cause of long-term disability and the second leading cause of death
worldwide.1 Strokes are either ischemic, which account for over 85% of all strokes and occur
due to the interruption of blood flow caused by thrombosis, or hemorrhagic, which occur due to
bleeding.2,3 During ischemic stroke, a reduction or complete loss in blood supply causes a
starved oxygen environment and leads to neuronal damage within minutes and ultimately to
sensorimotor and cognitive impairment.2,3
Animal models provide a great tool to study the structural and functional consequences of
ischemic stroke as well as to develop therapeutic methods to promote recovery after stroke.4–6 In
order to maximize the translation of preclinical research to the clinical setting, it is essential that
animal models of stroke mimic the biology of human stroke.5,7–9 The most commonly used ani-
mal model of ischemic stroke is occlusion of the middle cerebral artery (MCA), which is usually
induced by direct mechanical blocking of blood flow via a suture inserted through the carotid
artery.10,11 One of the disadvantages of this model is the use of anesthetics in order to perform the
occlusion as anesthetics are potential confounding factors that alter neuronal function and cer-
ebral blood flow (CBF).12–14 Another drawback of this technique is the difficulty in monitoring
changes to blood flow during occlusion since the animal is on its back during the procedure.11
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Although a recent study has shown the ability to perform MCA occlusion in a semiawake
setting, the animal preparation is acute and does not allow longitudinal monitoring of stroke
progression.15 Other currently used models of ischemic stroke are through ferric chloride–
induced vascular thrombosis,16 endothelin-1–induced vasoconstriction,17 or thrombin injection.18
However, these models also suffer from the drawbacks of using anesthetics, being acute prep-
arations, and requiring invasive surgery without recovery to induce stroke.
Another common model of ischemic stroke is photothrombosis, which induces ischemic
stroke by photoactivation of a photosensitive dye.19 Illumination of the injected dye with a spe-
cific wavelength of light triggers a clotting cascade and leads to thrombosis. An advantage of this
method is that it can be performed in an awake animal, eliminating anesthetics as a confounding
factor.20 Additionally, simultaneous imaging of CBF changes or other physiological parameters
such as tissue oxygen can be performed during photothrombosis, which can further our under-
standing of the mechanisms involved during stroke.21 Photothrombosis also offers the benefit of
targeting a specific region by selectively illuminating a region of interest, such as the forelimb
region or the barrel cortex in rodents, to study the functional consequences of stroke on specific
behaviors over weeks and even months.22–24 However, a disadvantage of illuminating a func-
tionally distinct cortical area is the nonphysiological nature of photocoagulating an area of
the brain.25 This technique of direct cortical illumination leads to widespread thrombosis of all
vasculature within the illumination field, including arteries, arterioles, venules, and capillaries.
In a natural situation, only the artery supplying the field is occluded. To maximize the relevance
of animal models to human stroke, it is crucial to target individual vessels and minimize
unwanted photoactivation-induced damage to the tissue surrounding the target vessel. Previous
studies, albeit under anesthesia, have shown the ability to occlude surface arterioles or individual
penetrating arterioles using photothrombosis by controlling the parameters of laser illumination
in order to minimize photodamage to adjacent and deeper vessels.26–28
Although photothrombosis has been performed in awake animals29 and has also been used to
target individual vessels,26 these methods have not been previously combined. Here we combine
the benefits of formerly used techniques to create a chronically prepared mouse photothrombosis
stroke model that induces targeted ischemic stroke in awake mice while simultaneously mon-
itoring macroscopic changes to CBF. We show the benefits of targeted illumination through
Monte Carlo simulations as well as the benefits of guiding illumination using real-time feedback
of CBF through in vivo measurements. As shown through laser speckle contrast imaging (LSCI)
and behavioral evaluation, this method leads to the formation of a reliable stroke with a func-
tional deficit, which can be monitored chronically to study recovery mechanisms following
stroke or to test the effects of potential therapeutics on the recovery process.
2 Methods
2.1 Instrumentation
A schematic of the imaging system used for photothrombotic stroke is shown in Fig. 1(a). To
induce an occlusion in a distal pial branch of the MCA and simultaneously monitor changes to
CBF, the photothrombosis setup was coupled together with a laser speckle imaging system. The
photothrombotic arm of the setup consists of a 520-nm laser diode (L520P50, 50 mW, Thorlabs)
to photoactivate Rose Bengal via epi-illumination. A scan lens, which consists of three plano-
convex lenses and tube lens combination, as shown in Fig. 1(b), was used to fill the back pupil of
a 2× objective in order to obtain a focal spot with a lateral resolution of 6 μm in diameter and an
axial point spread function of 104 μm. A neutral density filter along the imaging path allowed
visualization of the illumination spot through a multispectral camera by avoiding oversaturation
of the camera (Hamamatsu ORCA-Flash4.0 V3). By illuminating the cranial window with a blue
light emitting diode (LED), the surface vasculature can also be visualized through the multi-
spectral camera, thus making it possible to image the vasculature while performing photothrom-
bosis. A 650-nm short-pass filter was placed along the path to prevent bleed through from
the 785-nm laser diode used for laser speckle imaging. Simultaneous LSCI was performed by
illuminating the cranial window using a VHG stabilized 785-nm laser diode30 (LP785-SAV50,
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Thorlabs) at a power density of ∼10 mW∕cm2 to provide an optimal contrast range and
signal-to-noise ratio.31 The back scattered light was imaged onto a CMOS camera (Basler
acA2040-90 μm NIR, 2048 × 2048 pixels, 5.5 × 5.5 μm pixel size) with a 2× magnification
for a field of view of 5.6 mm × 5.6 mm. A 640-nm dichroic was used to split the visible and
near-infra-red illumination. A polarizer and iris in the imaging path were used to reduce specular
reflection and optimize for the speckle size, respectively. Images were acquired at 40 frames
per second with a 5-ms exposure. Real-time spatial laser speckle contrast was calculated from
the raw images captured using software from the Functional Optical Imaging Laboratory at
the University of Texas at Austin.32
2.2 Surgical Procedure
All animal procedures were approved by the Boston University Institutional Animal Care and
Use Committee and were conducted following the Guide for the Care and Use of Laboratory
Animals. All mice used in this study were adult WT C57Bl6 at ∼12 weeks old during the time of
surgery. There were two groups of three mice each to validate our optimized and nonoptimized
photothrombotic stroke protocols, three mice were used to assess behavioral changes after
stroke, and an additional three mice were used for histological analysis.
Mice were anesthetized using isoflurane (3% induction, 1% to 1.5% maintenance, in
1 L∕min oxygen). Dexamethasone was administered 4 h prior to the start of the procedure
to minimize tissue swelling during surgery. Body temperature was maintained at 37°C and mice
were monitored using respiratory rate and toe pinch throughout the procedure. A craniotomy was
performed over one hemisphere of the brain and the skull was removed leaving the dura intact.
The surface was covered with a half-skull-shaped curved glass33 (modified from Crystal Skull,
LabMaker, Germany) and sealed with dental acrylic. An aluminum bar was attached to the intact
skull on the other hemisphere for head fixing the mice during photothrombosis and imaging.
Animals were given buprenorphine and a prophylactic dose of cefazolin to reduce pain and
risk of infection following surgery. The mice were allowed to recover from surgery for at
least 10 days before head fixation. Mice were trained to become accustomed to head fixation
for up to 1 h for ∼10 days before performing photothrombosis. All experiments are done in
awake head-fixed mice.34–36 A cranial window and head-bar illustration and preparation is
shown in Fig. 1(c).
Fig. 1 (a) Schematic of imaging setup with combined LSCI, intrinsic signal imaging, and photo-
thrombosis. A parts list for this setup is included in Table S2 in the Supplementary Material.
(b) Zemax model of photothrombosis via epi-illumination. (c) (top) Illustration of cranial window
and head-bar placement; (bottom) representative image of cranial window and head-bar immedi-
ately after surgery. (d) Intrinsic optical signal imaging of change in total hemoglobin concentration
during air puff stimulation of the contralateral forelimb. Black circle indicates the vessel targeted for
photothrombotic occlusion.
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2.3 Intrinsic Optical Signal Imaging
In order to determine the target vessel for photothrombotic occlusion, we performed intrinsic
optical signal imaging during air puff sensory stimulation of the contralateral forelimb. Awake
head-fixed mice were placed under the imaging setup shown in Fig. 1(a). Three LEDs with
center wavelengths at 470, 530, and 625 nm (MXL3-C1, Thorlabs, X is the center wavelength)
were used to sequentially illuminate the cranial window at 30 Hz (10 Hz per wavelength).
Images were collected by the sCMOS camera (Hamamatsu ORCA-Flash4.0 V3). For sensory
stimulation, each trial consisted of a 5-s train of air puffs at 3 Hz delivered to the forelimb con-
tralateral to the hemisphere implanted with the cranial window. We obtained 20 trials where each
trial was obtained in a block-design fashion and consisted of 5 s of baseline, followed by 5 s of
stimulation, followed by 20 s of recovery. A customMATLAB code was used to synchronize and
trigger the sequential LEDs, camera acquisition, and air puff stimulation.
We computed changes in oxy-hemoglobin (HbO) and deoxy-hemoglobin (HbR) from the
acquired images using the modified Beer–Lambert relationship. Briefly, from the sequence
of images acquired, we computed the change in optical density (OD) at each wavelength for
each pixel as
EQ-TARGET;temp:intralink-;sec2.3;116;537ΔODðλ; tÞ ¼ − ln

Iðλ; tÞ
I0ðλÞ

;
where Iðλ; tÞ is the reflected light intensity at wavelength λ and time t, and I0ðλÞ is the baseline
intensity (first 5 s of every trial). Using the modified Beer–Lambert law:
EQ-TARGET;temp:intralink-;sec2.3;116;468Iðλ; tÞ ¼ I0ðλÞ exp½−Δμaðλ; tÞLðλÞ;
where Δμaðλ; tÞ is the change in optical absorption coefficient and LðλÞ is the wavelength-
dependent mean free path length in the tissue as estimated by Kohl et al.37 through Monte
Carlo simulations of light propagation in tissue, we estimated Δμaðλ; tÞ at each wavelength for
each pixel. Using the estimated changes in absorption coefficients, we calculated changes in
HbO and HbR for each pixel at each time using a set of three equations and the molar extinction
coefficients of HbO and HbR:
EQ-TARGET;temp:intralink-;sec2.3;116;365Δμaðλ; tÞ ¼ ϵHbOðλÞΔHbOðtÞ þ ϵHbRðλÞΔHbRðtÞ:
Total hemoglobin HbTwas calculated as a sum of HbO and HbR. HbT for 20 trials was averaged
and the spatial map for change in HbTwas obtained for the 5-s stimulus period. This spatial map
was used to determine the branch of the MCA that supplied the forelimb region, which was the
target branch for photothrombotic occlusion. Figure 1(d) shows a representative spatial map of
change in HbT during forelimb activation.
2.4 Focal Cerebral Ischemia
To induce an occlusion in a distal pial branch of the MCA, while causing minimal damage to the
surrounding parenchyma, we used a modified version of photothrombosis previously described
by Watson et al.19 The 520-nm collimated laser diode was tuned to a postobjective power of
0.6 mW, which was shown to be sufficient to occlude the target vessel. The postobjective laser
power was measured just below the focus before the start of each photothrombosis experiment.
For illumination, the branch of the MCA supplying the forelimb region was identified using
a response map obtained by intrinsic optical signal imaging during forelimb stimulation. Mice
were head-fixed and positioned under the imaging system so that the illumination spot was on
the target vessel. A translation stage was used for bulk positioning of the mouse and a kinematic
steering mirror was used for fine changes to steer the laser beam to the target vessel. The
vasculature was visualized under blue light with a multispectral camera. Since Rose Bengal is
activated with green light, blue light was used to visualize the vasculature to prevent any
unwanted photoactivation. Baseline CBF was obtained using LSCI for 10 min prior to the start
of photothrombosis. Rose Bengal (100 μl, 15 mg∕ml in saline) was injected retroorbitally while
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the mouse was anesthetized briefly with isoflurane. The active use of isoflurane, during induc-
tion and retroorbital injection, was limited to a minute. Isoflurane was immediately discontinued
after injection and the mice were allowed to recover from anesthesia, as determined by a return to
baseline blood flow in the real-time laser speckle contrast images as well as exhibiting natural
behavior such as whisking, before performing photothrombosis.
One set of animals underwent traditional photothrombosis (nonoptimized protocol) where
the target vessel was illuminated for 15 min, and the other set of animals underwent optimized
photothrombosis (optimized protocol), where real-time laser speckle contrast feedback was used
to guide the duration of illumination. In the optimized protocol, when the target vessel was
occluded, as indicated by the branch disappearing during real-time LSCI, the 520-nm laser was
decreased in power to half (0.3-mW postobjective) for 2 min and then turned off. If the branch
reperfused, as indicated by a return in blood flow as seen in real-time LSCI, during the 1 h that
the mice were monitored under LSCI, the 520-nm laser was turned on until the vessel was
occluded again. Sufficient Rose Bengal was present in the blood stream over an hour after injec-
tion as shown in Fig. S1 in the Supplementary Material and can be in the blood stream for several
hours after injection.38,39 Similar to other studies, we found it necessary to target and occlude
collateral branches in addition to the main target vessel in order to stabilize the effects of the
stroke, since collateral supply or even flow reversal can prevent a single vessel occlusion from
having a significant reduction in blood flow in the target region.26,40 Collateral branches were
determined on a case-by-case basis by observing flow redistribution in the MCA-supplied field
using the real-time LSCI feedback.
To distinguish between a passive circulatory collapse or distal microembolism in the nearby
capillary network closest to the illumination point and a direct capillary photothrombosis near
the illumination area, we tested our protocol in an additional animal, to thrombose two separate
pial veins with both the optimized and nonoptimized illumination strategies. Those targeted
veins were of similar size to the previously targeted arterioles to allow comparison. When a
cortical vein is thrombosed at a single focal point, we can still expect at least some degree
of redistributed flow in the nearby upstream capillary bed close to the illumination area, which
can be easily detected with optical coherence tomography (OCT) angiography. This way,
we could avoid the effect of microemboli and a passive circulatory collapse, better revealing
the directly photothrombosed zone.
2.5 Optical Coherence Tomography
OCTwas used to obtain angiograms of the vasculature at the site of illumination before and after
photothrombosis to analyze the vascular damage. A spectral domain OCT system (1310-nm
center wavelength, bandwidth 170 nm, Thorlabs) was used for obtaining angiograms as
described previously.41 Briefly, OCT-angiograms were obtained using a frame-to-frame subtrac-
tion of the repeated complex OCT B-scan signal. Static tissue will show no (or very low) differ-
ence between the repeated B-scans and will appear as dark regions in the OCTangiogram. On the
other hand, moving red blood cells within a vessel will cause OCT signal fluctuations resulting in
a large intensity difference between the repeated B-scans and will show up as bright areas in the
OCT angiogram. A 600 × 600 μm2 region around the target vessel was imaged before stroke
and 1 h after stroke. The region was scanned with 400 × 400 pixels to obtain a pixel size of
1.5 × 1.5 μm2. Each OCT angiogram was repeated 20 times to obtain an average of 20
angiograms. The transverse and axial resolutions of the OCT system using a 10× objective
(Mitutoyo) were 3.5 μm × 3.5 μm × 3.5 μm.
2.6 Histological Analysis
In order to confirm the formation of an infarct, we performed histological staining with tri-
phenyl-tetrazolium chloride (TTC) on fresh tissue at 24 h after photothrombosis on two mice.
TTC staining is used to differentiate between metabolically active and inactive tissue and is
commonly used to identify infarcted tissue. The mice were deeply anesthetized with isoflurane,
decapitated, and their brains were removed for TTC staining. The intact brain was incubated at
37°C for 30 min in 2% TTC in 1 × PBS. Images were acquired immediately after staining.
Sunil et al.: Awake chronic mouse model of targeted pial vessel occlusion via photothrombosis
Neurophotonics 015005-5 Jan–Mar 2020 • Vol. 7(1)
To assess the damage done to tissue at the illumination site, we stained for necrotic and
apoptotic cells using propidium iodide (PI). PI is a fluorescent marker that binds to DNA of
a cell but is not membrane permeable. This allows us to differentiate necrotic and apoptotic
tissue from healthy cells. Mice were injected with 300 μl of 1 mg∕ml of PI diluted in
300 μl of saline intraperitoneally 24 h after photothrombosis. We performed in vivo two photon
imaging of PI 3 h after injection at the illumination site and the stroke core. The mice were
perfused 4 h after PI injection with heparinized PBS followed by a 10% w/v gelatin solution
in PBS with 30 mg∕ml of FITC-albumin in order to visualize the vasculature during ex vivo
imaging. The brains were extracted and transferred to 4% PFA for 6 h followed by 1 × PBS
for 3 days. The brains were then index matched with increasing concentration of fructose and
sliced at the location of the target vessel for occlusion. The brains were then mounted in 100%
fructose and imaged with a two-photon microscope to assess depth of tissue damage.
2.7 Behavioral Testing
The cylinder test was used in three mice to assess behavioral deficit in forelimb use over the
course of 4 weeks following stroke.42,43 Baseline testing was obtained the week before stroke
induction to assess basal preference in forepaw use. Following photothrombotic stroke mice
were tested at 4 h, 1 day, 3 days, 1 week, 2 weeks, 3 weeks, and 4 weeks. Each testing session
involved placing a mouse in a clear glass cylinder and videotaping its natural behavior from
below for 15 min. Forelimb use was assessed by counting the number of times the mouse used
each forelimb to make first contact with the cylinder wall during rears. Asymmetry in forelimb
use after stroke was quantified as a percent change from baseline use of the contralateral
forelimb. Change from baseline was used to compensate for the fact that some mice have a
preference for one paw over the other even before a stroke.
2.8 Data Analysis
Flow dynamics were analyzed offline through spatial speckle contrast by applying the com-
monly used model of blood flow index.44 The speckle contrast was calculated from raw images
captured by the camera using the following equation:
EQ-TARGET;temp:intralink-;sec2.8;116;362K ¼ σs
I
;
where the spatial speckle contrast (K) is defined as the ratio of the spatial standard deviation (σs)
and the mean intensity I of the pixels in a 7 × 7 bin. To provide a qualitative measure of blood
flow dynamics, the blood flow index was calculated using35
EQ-TARGET;temp:intralink-;sec2.8;116;287BFI ¼ 1
K2
:
OCT angiograms were analyzed for capillary density differences between the optimized and
nonoptimized photothrombosis protocols. A custom MATLAB code was used to segment the
vasculature and obtain the capillary density of a 150-μm-thick section of the 600 × 600 μm2
region of interest. Capillary segmentation was performed below the large surface vessels.
The mean and standard deviation of capillary density was compared before and after stroke for
the two groups. In addition to mean capillary density, the capillary density as a function of radial
distance from the illumination site was also calculated. Results are expressed as mean and stan-
dard deviations. Statistical analyses were made using an ANOVA with post hoc comparisons
using t-tests. For capillary densities, a two-sample t-test was performed to compare densities
before and after stroke for each protocols. Additionally, the two-sample t-test was used to com-
pare the capillary densities at different radial distances between the optimized and nonoptimized
protocols. For behavior analysis with the cylinder test, multiple pairwise comparisons were made
with the pair-sample t-test at each time point with respect to baseline. A p-value of <0.05 was
accepted as statistically significant. Individual p-values have been listed in Table S1 in the
Supplementary Material.
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3 Results
3.1 6-μm Spot is Superior to a 30-μm Spot in Preventing Capillary Damage
as shown by Monte Carlo Simulations
The photothrombosis laser was incorporated into an existing LSCI system via epi-illumination to
be able to simultaneously image changes to blood flow during vessel occlusion. To target a single
branch of the MCAwithout damaging the surrounding parenchyma, we designed a laser beam
path that resulted in the smallest spot size, given the imaging system’s parameters. Filling the
back aperture of a 0.1-NA objective resulted in a spot size with a lateral resolution of 6 μm in
diameter at the focus and a Rayleigh range of 60.8 μm. Zemax was used to design the required
scan lens in order to fill the back pupil of the 2× objective with a 200-mm tube lens. The required
beam profile was achieved with a combination of three planoconvex lenses that make up the scan
lens. The Zemax model of the photothrombosis arm is shown in Fig. 1(b). The true beam size
was validated and confirmed using a knife-edge beam profiler.
(a)
(b)
(c)
Fig. 2 (a) Monte Carlo simulation of photon density for (left) a 30-μm spot with numerical aperture
of 0.02 and (right) a 6-μm spot with numerical aperture of 0.1. (b) PI staining in vivo (left) and
ex vivo (right) at the site of illumination (circled in white). (c) PI staining in vivo (left) and ex vivo
(right) at the stroke core.
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Photon migration within the tissue for the 6-μm spot was modeled using a Monte-Carlo
simulation and compared against a simulation of a 30-μm spot size [Fig. 2(a)], since a number
of previous studies have used a 30-μm spot to perform targeted photothrombosis. A 30-μm spot
will have a very small NA of 0.02 and a Rayleigh range of 1.4 mm as shown in Fig. 2(a), result-
ing in less divergence of the beam. Thus power density falls off slowly for the 30-μm spot size,
which will result in damage of not only the target vessel but also all the vessels within the paren-
chyma down to 1 mm. However, a 6-μm illumination spot has an NA of 0.1 and the beam
diverges more quickly such that any parenchymal photothrombotic damage will be limited
to ∼150 μm below the target vessel as the power density beyond that depth drops below the
threshold for activating Rose Bengal.
Tissue damage in depth due to illumination with the 6-μm spot was validated in vivo and ex
vivo using PI staining of damaged cells. Figure 2(b) shows damage at the target vessel location
where the left panel indicates PI staining in vivo at 60-μm depths apart starting from the surface
and the right panel shows damage ex vivo. PI positive cells are no longer visible at 180 μm below
the surface, which was confirmed ex vivo where the damage was also limited to 150 to 200 μm
below the surface. This was in contrast to damage observed at the stroke core [Fig. 2(c)], which
was over 500 μm away from the illumination site and any damage was due to occlusion itself and
not the illumination. PI positive cells are present even at 300 μm below the surface in vivo as
shown in the left panel of Fig. 2(c) and the full extent of the stroke core is shown ex vivo in the
right panel of Fig. 2(c) where it extends deep into cortex.
3.2 Optimized and Nonoptimized Methods Produce an Ischemic Stroke
Typically, previous studies have used a fixed duration of 10 to 15 min of laser illumination to
occlude the target vessel.20,39,45 Following a similar protocol, in one group of animals, we illu-
minated our target vessel for 15 min with a laser power of 0.6 mW. We call this nonoptimized
protocol. Occlusion was confirmed by measuring a greater than or equal to 80% drop in the
qualitative blood flow index with LSCI and also a >50% decrease in the region supplied by
the target vessel by monitoring real-time spatial LSCI feedback. For the optimized group,
we used real-time LSCI feedback to guide the duration of illumination. Both the nonoptimized
and optimized groups showed an 80% decrease from baseline CBF in the target vessel as seen in
the time course of the relative blood flow changes in the bottom panel of Figs. 3(a) and 3(b).
Additionally, the regions supplied by the target vessel showed similar patterns of change in CBF
from baseline in both groups [Figs. 3(a) and 3(b)]. The stroke core, which is the area supplied by
the target vessel and indicated by region 1, sees a 60% drop in blood flow in both groups. Region
2 is shown as a representative region selected away from the tissue supplied by the target vessel.
CBF analysis is not provided for the periods when the collaterals were targeted, as indicated
by breaks in the CBF time course plots since we needed to reposition the mouse so that the
desired vessel was directly under the illumination spot. The collaterals targeted are shown with
black arrows in the leftmost reference images in Figs. 3(a) and 3(b). We found it necessary to
target two collaterals on average to stabilize the effects of the stroke. An example collateral target
is shown in Fig. 3(c) with the black circle. The top panel shows real-time laser speckle contrast
images and the bottom panel shows the associated change in blood flow compared to baseline.
We followed the same parameters of the optimized protocol to target the collaterals, where the
illumination was turned on until the vessel was occluded following which the laser was turned
off and the mouse repositioned to the original location. If the collateral branches recanalized, the
mouse was moved again in order to occlude them. The time course of collateral occlusion is
represented by breaks in the CBF time course in Figs. 3(a) and 3(b).
The optimized protocol used real-time laser speckle feedback to guide the duration of illumi-
nation of the target vessel. The green shaded region of the time course in Fig. 3 is when the 520-nm
laser was on. After the initial occlusion period, the laser was turned on again when the target vessel
recanalized, as shown by representative images in Fig. 3(d). A return of blood flow, indicated by a
drop in laser speckle contrast signal intensity, was used as the criteria to turn the laser on, and a
subsequent occlusion, indicated by an increase in signal intensity, was used to turn the laser off.
This criteria for a return of blood flow and the subsequent occlusion are qualitative measures that
are easily visualized in real-time laser speckle contrast images as the entire branch recanalized or
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(b)
(a)
Fig. 3 Relative CBF maps during photothrombosis. (a) Relative CBF during nonoptimized photo-
thrombosis and (b) during optimized photothrombosis. Top panel shows spatial blood flow dynam-
ics and bottom panel shows temporal dynamics for the regions specified in the top panel. Leftmost
image in the top panel of (a) and (b) shows a reference indicating the target vessel in magenta
arrows and collateral branches targeted for occlusion in black arrows. Both nonoptimized and
optimized protocols show similar blood flow dynamics during occlusion. Green shaded region
on the bottom panel corresponds to photothrombosis laser ON periods. (c) Representative images
showing collateral occlusion (circled in black). Top panel shows laser speckle contrast images as
visualized in real time. Bottom panel shows relative blood flow changes associated with the occlu-
sion. The region shown is represented as the black square in the reference image of the top panel
of (b) and the time course chosen for images in (c) is shown as the first black square indicated as
“C” at the bottom panel of (b). (d) Representative images showing criteria for laser ON/OFF peri-
ods in the optimized protocol. The time course chosen for images is shown as the second black
square indicated as “D” in the bottom panel of (b). Laser is turned on when the target vessel recan-
alizes, indicated with a drop in intensity in real-time laser speckle contrast, and turned off when the
vessel is occluded again, indicated with an increase in signal intensity of the target vessel.
(e) Video 1 showing real-time laser speckle contrast as seen during photothrombosis (left panel)
and the associated blood flow changes (right panel). Since the mouse is being moved during col-
lateral branch illumination, those segments have been removed for ease of visualization of the
spatial dynamics observed during photothrombosis (Video 1, 13.6 MB, MP4 [URL: https://doi
.org/10.1117/1.NPh.7.1.015005.1]).
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disappeared, respectively. Avideo showing real-time laser speckle contrast and the associated CBF
changes is included to better visualize the effects of photothrombosis (see Video 1).
3.3 Optimized Method is Superior to the Nonoptimized Method
in Preventing Capillary Thrombosis
The effect of photothrombosis on blood flow in the surrounding capillaries was assessed in vivo
using OCT angiograms. The difference between image intensities of two repeated B-scans per-
mits the detection of flowing capillaries. Figure 4 shows the average OCTangiograms of both the
nonoptimized and optimized photothrombosis methods for three mice in each group. In Fig. 4(a),
(c)
(d)
(e)
Fig. 3 (Continued.)
(a) (b) (c)
Fig. 4 (a) OCT angiograms of flowing vessel before stroke (top panel) and 1-h after nonoptimized
stroke (bottom panel). (b) OCT angiograms of flowing vessel before stroke (top panel) and 1-h
after optimized stroke (bottom panel). (c) Vein thrombosis after nonoptimized stroke (top panel)
and after optimized stroke (bottom panel). The target vessel is shown by the red circle.
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we show that after nonoptimized photothrombosis there is a significant decline in capillary den-
sity immediately surrounding the targeted pial artery compared to before stroke. The left panel in
Fig. 4(a) also shows that 1 h after stroke, even though the surrounding parenchymal capillaries
remained occluded, the target branch has recanalized. This indicates that the traditional method
of illuminating the target vessel for a fixed longer duration is not necessarily sufficient to occlude
the vessel for even 1-h poststroke, but has produced a persistent cessation of blood flow in the
immediate vicinity. These capillaries have been photothrombosed because of the prolonged laser
exposure in the nonoptimized method, and while the pial artery has recanalized in this case, the
capillaries have not because of their smaller diameter stabilizing the thrombi in the capillaries.
Figure 4(b) shows the averaged OCT angiograms for the optimized protocol and we see that
just the illuminated target vessel is occluded and all the surrounding capillaries are intact. Both
the optimized and nonoptimized protocols show spontaneous recanalization in the target vessel
after photothrombosis in some cases. Any drop in surrounding vessel density in the optimized
protocol is due to block of capillaries downstream of the target vessel. This can be shown by
thrombosing a vein as veins do not have any downstream capillaries and hence the capillary
network should remain intact unless directly illuminated by the laser. Figure 4(c) shows a vein
photothrombosis with the optimized and nonoptimized protocol. We see that with the optimized
protocol only the target vessel is thrombosed and the capillary network within the immediate
vicinity is intact, whereas in the nonoptimized protocol, the capillary network around the target
vessel is also thrombosed. The optimized laser illumination ensures that the laser exposure to the
capillaries remains below the threshold for photothrombosis to occur.
Quantitative analysis of vessel density also shows a decrease in capillary density for the
nonoptimized photothrombosis, as seen in Figs. 5(b) and 5(c). Figure 5(a) shows an example
OCT angiogram before and after stroke (left column), with the red circle indicating the site of
laser illumination. The middle panel of Fig. 5(a) shows the maximum intensity projection of
the segmented vasculature of the same example mouse for a 150-μm-thick section of capillaries.
In order to look at the capillary density, as a function of distance from the site of occlusion we
constructed 50 μm rings starting at 100 μm from illumination center and out to 300 μm.
Figure 5(b) shows the capillary density for the full imaged region before and after stroke aver-
aged across three mice for each group. The nonoptimized protocol shows a significant decrease
in capillary density after stroke compared to before stroke (p < 0.05), whereas the optimized
(a) (b)
(c)
Fig. 5 (a) Example schematic of vascular segmentation in the optimized protocol. Left column
shows an example angiogram with occlusion site within the red circle. Middle column shows
capillaries segmented beneath the larger pial vessels. Right column shows 50 μm concentric rings
used to calculate capillary densities as a function of distance from the occlusion site. (b) Average
vessel density for nonoptimized and optimized methods before and 1-h after stroke. The nonop-
timized protocol shows a significant decrease in capillary density after stroke compared to
before stroke (*p < 0.05). (c) Capillary density as a function of distance from the occlusion site
normalized to the baseline capillary density. Capillary density of the nonoptimized method was
significantly less than that of the optimized method at distances >150 μm from the occlusion site
(*p < 0.05).
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protocol does not show a significant decrease in capillary density. When looking at the capillary
density as a function of distance from illumination, we see that the capillary density of optimized
protocol returned to baseline levels at 150 to 200 μm from the center as shown in Figure 5(c).
However, the capillary density of the nonoptimized protocol remained at <50% of baseline ves-
sel density out to 300 μm. Capillary density of the nonoptimized method was significantly less
than that of the optimized method at >150 μm from the occlusion site (p < 0.05).
3.4 Formation of a Stable Infarct was Confirmed Using Blood Flow Changes,
Histological Validation, and Behavioral Analysis
In this study, we are capable of simultaneously monitoring changes to blood flow during stroke
induction. This allows us to visualize and confirm in real time the occlusion of the target vessel as
well as a drop in blood flow to the area supplied by the vessel. Figure 6(a) shows a representative
image of relative CBF 1 h after photothrombosis. We observed a greater than 80% drop in blood
flow within the target vessel and greater than 50% decrease in blood flow in the region supplied
by the target vessel. TTC staining of viable tissue was used to confirm infarct formation at 24 h
after photothrombosis in a subset of animals. Figure 6(b) shows infarcted tissue corresponding to
the region of low blood flow in Fig. 6(a). The target vessel is marked with black circles. In
addition to decreased blood flow and histological damage, we monitored change in contralateral
forelimb use with the cylinder test at various time points following photothrombosis. We
observed a decrease in use of the forelimb contralateral to the ischemic hemisphere (impaired
forelimb) when compared to baseline use as shown in Fig. 6(c). There was a significant decrease
(p < 0.05) in the use of the impaired forelimb till one week after photothrombosis, following
Fig. 6 (a) Relative CBF at 1 h after photothrombosis. The target vessel is indicated with the
black circle. (b) TTC stain at 24 h after photothrombosis. The infarct site coincides with the area
of reduced CBF (<60% of baseline) shown in (a). (c) Percent change in paw use of the
impaired forelimb (contralateral to stroke) over the course of 4 weeks. Mice showed a signifi-
cant decrease in the use of the impaired forelimb specifically till 1 week following photothrom-
bosis. *p < 0.05.
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which behavior trended toward recovery to baseline. With these metrics, we can confirm that
our optimized photothrombotic stroke model can produce a reliable infarct with associated
functional deficits.
3.5 Chronic Use of Our Model Was Validated Using Longitudinal
Imaging of Vasculature
Our cranial window preparations allow longitudinal monitoring in awake mice, which can be
used to study stroke recovery mechanisms or the long-term effects of therapies. Here we show
that we are able to follow vascular structure using two-photon microscopy for one month fol-
lowing photothrombosis (Fig. 7). Although we followed the vasculature for one month, in which
point the mice were sacrificed for ex vivo analyses, the mice can be monitored for even longer
time points if desired since one-month poststroke showed minimal deterioration to the window
quality. An inflammatory response that results due to the lesion could cause cellular build up
under the window which could deteriorate the quality of the window. However, that deterioration
is minimal and we are able to penetrate to 400 μm below the surface with sufficient signal-to-
background ratio. In order to test the longevity of the cranial windows, we have followed control
mice for 6 months and expect that the stroked mice can also be followed for that long. Thus our
model is ideal for longitudinal stroke studies and can be used to study various physiological
parameters across a number of imaging modalities.
4 Discussion
We have developed a chronic animal model that can be used to induce ischemic stroke in awake
mice while monitoring changes to CBF. We also show that the limited laser spot size and real-time
CBF permits us to occlude a target pial artery without occluding the surrounding and underlying
capillaries. Although a number of previous models have performed single-vessel occlusion and
produced the desired ischemic core and peri-infarct zone, they were performed on anesthetized
mice.25,26,28,46 Anesthetics are known to modulate blood flow, which could impact the mechanisms
leading to parenchymal failure after a stroke.12–14,47 Additionally, it has been shown that anesthetics
can mask the benefits of a neuroprotective therapy.20 A study has shown the ability to use an MCA
occlusion model without the effects of anesthesia, but the animal preparation is acute and does not
allow the animals to recover from surgical procedures, which could be a confounding factor.15 Our
(a)
(b)
Fig. 7 Two-photon maximum intensity projections (left) and volumes (right) of 400 μm stack
(a) 5 days before photothrombosis and (b) 4 weeks after photothrombosis. Red circle indicates
vessel targeted for photothrombosis. Red square indicates regions chosen for volume projections.
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model uses a cranial window preparation that is performed three weeks prior to stroke induction,
allowing the mouse time to recover from the surgery. Additionally, our cranial windows allow
longitudinal monitoring of stroke recovery mechanisms, which can be used to study long-term
stroke progression or the long-term effects of therapies.
The photothrombotic stroke model is advantageous for studying the mechanisms of the func-
tional, structural, and behavioral responses involved in stroke recovery due to its ability to pre-
cisely target a desired region.21–24,48 However, a drawback of directly targeting an anatomically
distinct area, which includes larger vessels and parenchyma, using photothrombosis, is the
relatively small ischemic penumbra that results due to oxidative damage primarily within
the ischemic core, rather than gradually distributed in the peri-infarct zone.5,6,25 This hinders the
understanding of how mechanisms within the peri-infarct influence functional recovery. In this
paper, we have shown that targeting an upstream branch of the MCA supplying a functionally
distinct area is capable of creating an infarct core in the area it supplies as seen by >60% drop in
blood flow, as well as a penumbra as seen by a 40% to 60% drop in blood flow in the area
surrounding the ischemic core. This method of artery targeted photothrombosis that leads to
a widened vascular penumbra suitable to study recovery mechanisms within the peri-infarct zone
has also been shown previously by Clark et al.25 We have also shown in our present study that
our model is capable of targeting a distinct functional area of the forelimb representation that
produces longitudinally quantifiable deficits in forelimb use.
Additionally, through Monte Carlo simulations, we have shown that the size of the beam used
to occlude the target vessel must be considered in order to minimize unwanted photodamage to
the surrounding parenchyma. We have shown that it is not sufficient to decrease the lateral res-
olution of the illumination spot to the size of the branch being targeted. The size of a distal MCA
is ∼30 to 50 μm, and a spot size with a lateral resolution of 30 μm will result in vascular damage
of over 1 mm beneath the target vessel. Decreasing the spot size to a 6-μm lateral resolution
resulted in significantly less unwanted vascular damage and was limited primarily to the target
surface vessel. Histological evidence validated that the parenchymal damage was limited to the
surface at the site of illumination, whereas the core showed damaged parenchyma deep in cortex.
Other groups have shown the ability to use photothrombosis to induce the desired core and
peri-infarct zones using variations of the vessel occlusion model. A number of single-vessel
occlusion models have been proposed that utilize an objective with higher magnification and
larger numerical aperture to target a region smaller than the vessel itself to minimize
photodamage.26,46 It typically involves starting laser illumination on one side of the vessel and
traversing the laser beam laterally to facilitate thrombus formation along the vessel. Although
this leads to negligible unwanted photodamage, it does not allow simultaneous macroscopic
imaging of CBF. These models also result in relatively small ischemic regions that are useful
for studying the effects of small strokes but are not large enough to follow functional recovery
mechanisms. Another model is artery-targeted photothrombosis using a digital micromirror
device to provide patterned illumination along the length of the artery with minimal exposure
to the surrounding parenchyma.21,25,49,50 This method also allows targeting multiple arteries
simultaneously, permitting illumination of collaterals together with the main branch and thus
controlling perfusion within the area. Some drawbacks of these methods are that photothrom-
bosis is still performed under anesthesia and the instrumentation is relatively more expensive and
difficult to implement.
In addition to spatially adjusting the laser illumination, we have also shown the advantages of
temporally controlling the duration of illumination. A previous study has mentioned the use of
real-time blood flow feedback to guide photothrombosis,27 and in this study we show that the
typically used fixed duration illumination protocol results in unwanted vascular damage and
optimizing that protocol to guided illumination using real-time blood flow feedback further min-
imizes damage to the surrounding parenchyma. The duration of illumination is limited to when
the target vessel is flowing as observed using LSCI. Capillary damage was analyzed by looking
at the density of flowing capillaries obtained from OCT, where we show an intact flowing capil-
lary network in the immediate vicinity of the occluded vessel in the optimized protocol as
opposed to the nonoptimized protocol. To rule out the possibility of downstream capillary throm-
bosis due to laser illumination, we performed optimized thrombosis on a vein, which did not
show any drop in capillary density apart from the target branch. However, vein photothrombosis
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using the nonoptimized protocol showed a similar drop in capillary density compared to artery
illumination with the nonoptimized protocol.
This photothrombosis stroke model also has a few limitations. One limitation is the brief use
of isoflurane during intravenous Rose Bengal injection. Although the use of isoflurane is limited
to a minute, it must be noted that there may be remnants of its effects even after the discon-
tinuation of anesthesia. As we are primarily concerned about the effects of isoflurane on blood
flow during photothrombosis, our criteria of recovery is the return of blood flow to baseline
levels as seen with real-time LSCI before the start of photothrombosis. A second limitation
is that the laser needs to be manually turned on and off to optimize the illumination duration.
This can be automated in the future by linking the real-time CBF from LSCI to the laser for
photothrombosis. Additionally, the mouse needs to be laterally translated when targeting the
collateral branches. This can also be improved upon by allowing a larger range of lateral control
of the laser beam.
In brief, this model is fairly easy and relatively inexpensive to implement and can be used for
experiments that more accurately mimic the mechanisms and recovery processes of ischemic
stroke and allows longitudinal monitoring of recovery mechanisms.
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